Significant reduction of the incidence of ovarian hyperstimulation syndrome (OHSS) by using the LHRH antagonist Cetrorelix in controlled ovarian stimulation for assisted reproduction. - Ludwig,M.; Felberbaum,R.E.; Devroey,P.; Albano,C.; Riethmüller-Winzen,H.; Schüler,A.; Engel,J.; Diedrich,K. (Arch Gynecol Obstet, 2000)